Engineered monoclonal antibody tobevibart enhances HBsAg capture by Fc receptor-positive cells and activates HBV-specific T cells

Authors:

Abstract
No abstract available
Funding Information
  • University of Utah
  • VIR Biotechnology Inc

This publication has 25 references indexed in Scilit: